Cargando…
Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab
Impaired immune response with uncontrolled inflammation and various immunological disorders have been reported during SARS-CoV-2 infection. Here, we report a case of cold agglutinin disease occurring during a severe coronavirus disease 2019 (COVID-19) in a French intensive care unit. A patient was p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058691/ https://www.ncbi.nlm.nih.gov/pubmed/35487646 http://dx.doi.org/10.1136/bcr-2021-242937 |